image_2_Equal Expansion of Endogenous Transplant-Specific Regulatory T Cell and Recruitment Into the Allograft During Rejection and Tolerance.TIF
Despite numerous advances in the definition of a role for regulatory T cells (Tregs) in facilitating experimental transplantation tolerance, and ongoing clinical trials for Treg-based therapies, critical issues related to the optimum dosage, antigen-specificity, and Treg-friendly adjunct immunosuppressants remain incompletely resolved. In this study, we used a tractable approach of MHC tetramers and flow cytometry to define the fate of conventional (Tconvs) and Tregs CD4+ T cells that recognize donor 2W antigens presented by I-Ab on donor and recipient antigen-presenting cells (APCs) in a mouse cardiac allograft transplant model. Our study shows that these endogenous, donor-reactive Tregs comparably accumulate in the spleens of recipients undergoing acute rejection or exhibiting costimulation blockade-induced tolerance. Importantly, this expansion was not detected when analyzing bulk splenic Tregs. Systemically, the distinguishing feature between tolerance and rejection was the inhibition of donor-reactive conventional T cell (Tconv) expansion in tolerance, translating into increased percentages of splenic FoxP3+ Tregs within the 2W:I-Ab CD4+ T cell subset compared to rejection (~35 vs. <5% in tolerance vs. rejection). We further observed that continuous administration of rapamycin, cyclosporine A, or CTLA4-Ig did not facilitate donor-specific Treg expansion, while all three drugs inhibited Tconv expansion. Finally, donor-specific Tregs accumulated comparably in rejecting tolerant allografts, whereas tolerant grafts harbored <10% of the donor-specific Tconv numbers observed in rejecting allografts. Thus, ~80% of 2W:I-Ab CD4+ T cells in tolerant allografts expressed FoxP3+ compared to ≤10% in rejecting allografts. A similar, albeit lesser, enrichment was observed with bulk graft-infiltrating CD4+ cells, where ~30% were FoxP3+ in tolerant allografts, compared to ≤10% in rejecting allografts. Finally, we assessed that the phenotype of 2W:I-Ab Tregs and observed that the percentages of cells expressing neuropilin-1 and CD73 were significantly higher in tolerance compared to rejection, suggesting that these Tregs may be functionally distinct. Collectively, the analysis of donor-reactive, but not of bulk, Tconvs and Tregs reveal a systemic signature of tolerance that is stable and congruent with the signature within tolerant allografts. Our data also underscore the importance of limiting Tconv expansion for high donor-specific Tregs:Tconv ratios to be successfully attained in transplantation tolerance.
History
References
- https://doi.org//10.1172/JCI90598
- https://doi.org//10.1084/jem.20012097
- https://doi.org//10.1111/j.1600-6143.2006.01489.x
- https://doi.org//10.1038/ncomms8566
- https://doi.org//10.1111/j.1600-6143.2010.03066.x
- https://doi.org//10.1084/jem.20110767
- https://doi.org//10.1084/jem.20041709
- https://doi.org//10.1038/nm.2155
- https://doi.org//10.4049/jimmunol.1200449
- https://doi.org//10.1111/ajt.13910
- https://doi.org//10.1002/eji.201040509
- https://doi.org//10.1016/j.jss.2011.03.021
- https://doi.org//10.1038/ni853
- https://doi.org//10.4049/jimmunol.168.11.5558
- https://doi.org//10.1002/eji.200838411
- https://doi.org//10.4049/jimmunol.180.10.6640
- https://doi.org//10.1182/blood-2006-05-025460
- https://doi.org//10.1038/nm1688
- https://doi.org//10.1172/JCI82771
- https://doi.org//10.1002/eji.201444743
- https://doi.org//10.4049/jimmunol.176.1.329
- https://doi.org//10.1172/JCI33185
- https://doi.org//10.1016/j.smim.2011.10.002
- https://doi.org//10.1038/nri2343
- https://doi.org//10.1016/j.it.2012.11.002
- https://doi.org//10.1182/blood-2011-02-337097
- https://doi.org//10.4049/jimmunol.1100519
- https://doi.org//10.1016/j.cell.2015.08.021
- https://doi.org//10.1038/nature13577
- https://doi.org//10.1016/j.immuni.2016.01.009
- https://doi.org//10.1073/pnas.0400084101
- https://doi.org//10.1038/nprot.2009.9
- https://doi.org//10.1016/j.immuni.2007.07.007
- https://doi.org//10.1073/pnas.1109806108
- https://doi.org//10.4049/jimmunol.180.9.5991
- https://doi.org//10.1073/pnas.0705240104
- https://doi.org//10.3389/fimmu.2017.01169
- https://doi.org//10.1097/TP.0000000000001379
- https://doi.org//10.1038/ni.3077
- https://doi.org//10.1038/ni.3004
- https://doi.org//10.1016/j.immuni.2014.10.012
- https://doi.org//10.1038/nri.2016.26
- https://doi.org//10.1056/NEJMoa1506027
- https://doi.org//10.1073/pnas.1402336111
- https://doi.org//10.1016/j.cell.2015.03.031
- https://doi.org//10.4049/jimmunol.0904028
- https://doi.org//10.1084/jem.20120914
- https://doi.org//10.1084/jem.20120822
- https://doi.org//10.1016/j.clim.2010.04.018
- https://doi.org//10.1002/eji.200839040
- https://doi.org//10.1371/journal.pone.0141161
- https://doi.org//10.1097/MOT.0b013e328355a992
- https://doi.org//10.1172/jci.insight.90088
- https://doi.org//10.1172/JCI71533
- https://doi.org//10.3389/fimmu.2018.00233
- https://doi.org//10.1172/JCI71359
- https://doi.org//10.3389/fimmu.2016.00549
- https://doi.org//10.3389/fimmu.2013.00497
- https://doi.org//10.1172/JCI46274
- https://doi.org//10.1111/j.1600-6143.2012.04055.x
- https://doi.org//10.1016/j.celrep.2015.12.099
- https://doi.org//10.1111/j.1600-6143.2007.01842.x
- https://doi.org//10.4049/jimmunol.0903805
- https://doi.org//10.1016/S1074-7613(00)80195-8
- https://doi.org//10.1111/j.1600-6143.2008.02377.x
- https://doi.org//10.1002/eji.200425143
- https://doi.org//10.1097/01.TP.0000093462.16309.73
- https://doi.org//10.1016/j.intimp.2011.03.021
- https://doi.org//10.1126/scitranslmed.3007607
- https://doi.org//10.1084/jem.20131556
- https://doi.org//10.1002/art.22414
- https://doi.org//10.1038/ni.2868
- https://doi.org//10.1016/j.cell.2016.07.006
- https://doi.org//10.1084/jem.20111497
- https://doi.org//10.1038/nature12428
- https://doi.org//10.1016/j.febslet.2015.07.027
- https://doi.org//10.1158/0008-5472.CAN-09-3109
Usage metrics
Read the peer-reviewed publication
Categories
- Transplantation Immunology
- Tumour Immunology
- Immunology not elsewhere classified
- Immunology
- Veterinary Immunology
- Animal Immunology
- Genetic Immunology
- Applied Immunology (incl. Antibody Engineering, Xenotransplantation and T-cell Therapies)
- Autoimmunity
- Cellular Immunology
- Humoural Immunology and Immunochemistry
- Immunogenetics (incl. Genetic Immunology)
- Innate Immunity